HER2-positive Primary Malignancy
1 clinical trials · Condition
◉ Watch HER2-positive Primary Malignancy
| Record | Firm | Date |
|---|---|---|
| Imaging With a New Agent That Finds a Cancer Protein Called HER2 (NCT03109977) | Memorial Sloan Kettering Cancer Center | 2017-03-31 |
Track HER2-positive Primary Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.